Small molecule activates citrullination through targeting PAD2
Philosophical Transactions of the Royal Society B: Biological Sciences · 2023
DOI: 10.1098/rstb.2022.0248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philosophical Transactions of the Royal Society B: Biological Sciences, 2023. Verfasst von Xue Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Tradi…. Hauptthemen laut MEDLINE: Citrullination, Histones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Shanghai Youth Talent Support Program.
Abstract (Originalsprache)
Citrullination is a post-translational modification catalysed by peptidyl arginine deiminase (PAD) enzymes, and dysregulation of protein citrullination is involved in various pathological disorders. During the past decade, a panel of citrullination inhibitors has been developed, while small molecules activating citrullination have rarely been reported so far. In this study, we screened citrullination activator using an antibody against citrullinated histone H3 (cit-H3), and a natural compound demethoxycurcumin (DMC) significantly activated citrullination. The requirement of PAD2 for DMC-activated citrullination was confirmed by a loss of function assay. Notably, DMC directly engaged with PAD2, and showed binding selectivity among PAD family enzymes. Point mutation assay indicated that residue E352 is essential for DMC targeting PAD2. Consistently, DMC induced typical phenotypes of cells with dysregulation of PAD2 activity, including citrullination-associated cell apoptosis and DNA damage. Overall, our study not only presents a strategy for rationally screening citrullination activators, but also provides a chemical approach for activating protein citrullination. This article is part of the Theo Murphy meeting issue ‘The virtues and vices of protein citrullination’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, People's Republic of China.
- Center for Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, People's Republic of China.
- School of pharmacy, Fudan University, Shanghai 201203, People's Republic of China.
- Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai 200233, People's Republic of China.
ORCID-Profile: Xisong Ke
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Shanghai Youth Talent Support Program
- Shanghai Municipal Education Commission
Zitieren
APA
Zhang, X., Shen, M., Zhu, H., Zhang, J., Yang, M., Su, K., Zhang, Y., Fu, W., Ke, X., & Qu, Y. (2023). Small molecule activates citrullination through targeting PAD2. Philosophical Transactions of the Royal Society B: Biological Sciences. https://doi.org/10.1098/rstb.2022.0248
Vancouver
Zhang X, Shen M, Zhu H, Zhang J, Yang M, Su K, et al. Small molecule activates citrullination through targeting PAD2. Philosophical Transactions of the Royal Society B: Biological Sciences. 2023. doi:10.1098/rstb.2022.0248
BibTeX
@article{Zhang2023,
author = {Zhang, Xue and Shen, Mengzhen and Zhu, Huimin and Zhang, Junjie and Yang, Min and Su, Kaiyan and Zhang, Yirong and Fu, Wei and Ke, Xisong and Qu, Yi},
title = {Small molecule activates citrullination through targeting PAD2},
journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
year = {2023},
doi = {10.1098/rstb.2022.0248}
}
EUVIMED